Inventiva's Speculative Upside Through MASH Is Promising

IVA is a high-risk, high-reward biotech stock hinging on lanifibranor’s Phase 3 NATiV3 MASH readout by Q4 2026. Click here to ...
Hosted on MSN

‘Trojan horse’ obesity drug tops GLP-1s in mouse tests

What was discovered: Researchers created a quintuple agonist that uses GLP-1 receptors to deliver a PPAR drug directly into target cells, reversing obesity and diabetes in mice. Why it matters: The ...
VegOut Magazine

Hybrid obesity drug smuggles second compound via Ozempic-style receptors, beats current treatments in mice

Researchers at Helmholtz Munich have engineered a hybrid obesity drug that uses GLP-1 receptors to smuggle a second metabolic ...
National Basketball Association

Current Opportunities

Apply today for an internship with the HBCU Pathways Program presented by Georgia Power for an opportunity to intern with the Atlanta Hawks this summer! The HBCU Pathways Program is a 10-week paid ...